KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEquity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueEBIATGross ProfitReceivables - NetReceivables Refunds
Ratios

Takeda Pharmaceutical (TAK) Shares Outstanding (2019 - 2025)

Takeda Pharmaceutical has reported Shares Outstanding over the past 7 years, most recently at $809432.6 for Q1 2025.

  • For Q1 2025, Shares Outstanding changed 0.18% year-over-year to $809432.6; the TTM value through Mar 2025 reached $809432.6, changed 0.18%, while the annual FY2025 figure was $810696.0, 0.02% changed from the prior year.
  • Shares Outstanding was $809432.6 for Q1 2025 at Takeda Pharmaceutical, down from $10.6 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $14.8 million in Q1 2021 and bottomed at $809432.6 in Q1 2025.
  • The 5-year median for Shares Outstanding is $10.6 million (2024), against an average of $8.1 million.
  • Year-over-year, Shares Outstanding soared 1080.05% in 2023 and then plummeted 93.1% in 2024.
  • Over 5 years, Shares Outstanding stood at $1.5 million in 2021, then plummeted by 32.91% to $995906.1 in 2022, then soared by 1080.05% to $11.8 million in 2023, then plummeted by 93.1% to $810882.7 in 2024, then decreased by 0.18% to $809432.6 in 2025.
  • The last three reported values for Shares Outstanding were $809432.6 (Q1 2025), $810882.7 (Q1 2024), and $11.8 million (Q1 2023) per Business Quant data.